News
Novo Nordisk Sues Eli Lilly Over Weight-Loss Drug Ads
Novo Nordisk says Lilly’s advertisements use outdated comparisons that omit the recently approved higher dose of Wegovy.
Novo Nordisk says Lilly’s advertisements use outdated comparisons that omit the recently approved higher dose of Wegovy.
Ozempic maker says pilots will start across R&D, manufacturing and commercial operations, with full integration due by end-2026
Delhi High Court pauses Olymviq rollout after Novo Nordisk argues the name is too close to Ozempic just days after semaglutide patent protection expired in India.